| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
0.95 |
| Metabolic Syndrome |
0 |
0.9 |
| Obesity |
0 |
0.85 |
| Aminotransferase |
0 |
0.67 |
| Liver |
0 |
0.66 |
| Fatty Liver |
0 |
0.6 |
| Hepatic Fibrosis |
0 |
0.57 |
| Liver Disease |
0 |
0.54 |
| Hepatocellular Carcinoma |
0 |
0.47 |
| Decompensated Liver Disease |
0 |
0.46 |
| Clinical Guidelines |
0 |
0.44 |
| Endocrinology |
0 |
0.35 |
| Primary Care |
0 |
0.35 |
| Type 2 Diabetes Mellitus |
0 |
0.23 |
| Bariatric Surgery |
0 |
0.13 |
| Referral |
0 |
0.13 |
| Cardiovascular Risk Management |
0 |
0.12 |
| Hypertension |
0 |
0.12 |
| Cardiometabolic Risk Factors |
0 |
0.11 |
| Cardiovascular disease |
0 |
0.1 |
| Child |
0 |
0.1 |
| Weight Loss |
0 |
0.1 |
| Weight Management |
0 |
0.09 |
| CT Scan |
0 |
0.07 |
| Cancer |
0 |
0.06 |
| Cirrhosis |
0 |
0.06 |
| Florida |
0 |
0.06 |
| Steatosis |
0 |
0.06 |
| Platelet Count |
0 |
0.05 |
| Adolescent Medicine |
0 |
0.03 |
| Biopsy |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Body Mass Index |
0 |
0.03 |
| Food and Drug Administration (FDA) |
0 |
0.03 |
| Health Care Cost |
0 |
0.03 |
| Indiana |
0 |
0.03 |
| Insulin Resistance |
0 |
0.03 |
| Metabolism |
0 |
0.03 |
| Nonalcoholic Steatohepatitis |
0 |
0.03 |
| Plasma |
0 |
0.03 |
| Portal Hypertension |
0 |
0.03 |
| Prediabetes |
0 |
0.03 |
| Preventive Screening |
0 |
0.03 |
| Scan |
0 |
0.03 |
| Surgery |
0 |
0.03 |
| Triage |
0 |
0.03 |
| Ultrasonography |
0 |
0.03 |